Patent ID: 11878016
Assignee: NEURIM PHARMACEUTICALS (1991) LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a subject diagnosed with an autism spectrum disorder, an intellectual disability, epilepsy, an anxiety disorder, a mood disorder, a disorder of social interaction, irritability, aggression, self-injurious behavior, hyperactivity, inattention, Fragile X syndrome, or diagnosed with elevated TNFα, or diagnosed with elevated inflammatory cytokine marker of neuroinflammation comprising administering ticagrelor, an enantiomer thereof, or a pharmaceutically acceptable salt thereof to the subject or administering a combination of ticagrelor, an enantiomer thereof, or a pharmaceutically acceptable salt thereof with a second agent in a weight ratio of 1:0.1 to 1:50 to the subject, wherein the administering does not include administering antioxidants.